The sales are part of a national pilot for VLN, the first cigarette to receive modified-risk orders.Read More
Tags :22nd Century Group
Treat brings experience from some of the world’s largest plant science companies. Read More
The firm is evolving from pure science to selling branded cigarettes and licensing IP. Read More
The firm says it chose Korea due to its smoking rate and commitment to harm reduction.Read More
New capabilities allow 22nd Century to create higher-value commercial lines.Read More
The FDA’s focus on nicotine is coming at the expense of true harm reduction. Read More
The move enhances the board’s scientific and commercialization experience. Read More
Following a pilot in March, the company will roll out its low-nicotine cigarettes nationwide. Read More
VLN King and VLN Menthol King are the first combustibles to be authorized as modified-risk. Read More
The deal will help advance R&D in the field. Read More
